Display options
Cite
Ramachandra CJA, Mai Ja KPM, Lin YH, et al. INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY. Cond Med. 2019;2(4):142-151
Ramachandra, C. J. A., Mai Ja, K. P. M., Lin, Y. H., Shim, W., Boisvert, W. A., & Hausenloy, D. J. (2019). INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY. Conditioning medicine, 2(4), 142-151.
Ramachandra, Chrishan J A, et al. "INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY." Conditioning medicine vol. 2,4 (2019): 142-151.
Ramachandra CJA, Mai Ja KPM, Lin YH, Shim W, Boisvert WA, Hausenloy DJ. INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY. Cond Med. 2019;2(4):142-151. PMID: 32457935; PMCID: PMC7250397.
Copy Download .nbib Format: NLM
Share it on

Cond Med. 2019;2(4):142-151.

INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.

Conditioning medicine

Chrishan J A Ramachandra, K P Myu Mai Ja, Ying-Hsi Lin, Winston Shim, William A Boisvert, Derek J Hausenloy

Affiliations

  1. National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  2. Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  3. Health and Social Sciences Cluster, Singapore Institute of Technology, Singapore.
  4. Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, USA.
  5. Yong Loo Lin School of Medicine, National University Singapore, Singapore.
  6. The Hatter Cardiovascular Institute, University College London, London, UK.
  7. The National Institute of Health Research University College London Hospitals Biomedical Research Centre, Research & Development, London, UK.
  8. Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico.

PMID: 32457935 PMCID: PMC7250397

Abstract

Hypertrophic cardiomyopathy (HCM) is one of the most commonly inherited cardiac disorders that manifests with increased ventricular wall thickening, cardiomyocyte hypertrophy, disarrayed myofibers and interstitial fibrosis. The major pathophysiological features include, diastolic dysfunction, obstruction of the left ventricular outflow tract and cardiac arrhythmias. Mutations in genes that encode mostly for sarcomeric proteins have been associated with HCM but, despite the abundant research conducted to decipher the molecular mechanisms underlying the disease, it remains unclear as to how a primary defect in the sarcomere could lead to secondary phenotypes such as cellular hypertrophy. Mounting evidence suggests energy deficiency could be an important contributor of disease pathogenesis as well. Various animal models of HCM have been generated for gaining deeper insight into disease pathogenesis, however species variation between animals and humans, as well as the limited availability of human myocardial samples, has encouraged researchers to seek alternative 'humanized' models. Using induced pluripotent stem cells (iPSCs), human cardiomyocytes (CMs) have been generated from patients with HCM for investigating disease mechanisms. While these HCM-iPSC models demonstrate most of the phenotypic traits, it is important to ascertain if they recapitulate all pathophysiological features, especially that of energy deficiency. In this review we discuss the currently established HCM-iPSC models with emphasis on altered energetics.

Keywords: Hypertrophic cardiomyopathy (HCM); cardiomyocytes; disease modelling; energetics; induced pluripotent stem cells (iPSCs); metabolism

References

  1. Sci Rep. 2017 Aug 17;7(1):8590 - PubMed
  2. Front Physiol. 2013 May 10;4:102 - PubMed
  3. J Clin Invest. 2002 Apr;109(8):1013-20 - PubMed
  4. Eur Heart J. 2017 Dec 7;38(46):3434-3440 - PubMed
  5. N Engl J Med. 2000 Feb 10;342(6):365-73 - PubMed
  6. Stem Cell Reports. 2018 Mar 13;10(3):834-847 - PubMed
  7. JACC Basic Transl Sci. 2018 Dec 31;3(6):728-740 - PubMed
  8. Heart Fail Rev. 2005 Sep;10(3):237-48 - PubMed
  9. J Clin Invest. 2006 Jan;116(1):209-16 - PubMed
  10. Circulation. 2011 Dec 13;124(24):2761-96 - PubMed
  11. J Mol Cell Cardiol. 2012 Jun;52(6):1299-307 - PubMed
  12. N Engl J Med. 1991 Jan 31;324(5):295-301 - PubMed
  13. Cardiovasc Res. 2010 Oct 1;88(1):16-29 - PubMed
  14. Hum Mol Genet. 2011 Dec 15;20(24):4851-64 - PubMed
  15. Sci Transl Med. 2012 Apr 18;4(130):130ra47 - PubMed
  16. Circ Res. 1999 Jul 9;85(1):47-56 - PubMed
  17. Circ Res. 2017 Sep 15;121(7):749-770 - PubMed
  18. J Am Coll Cardiol. 2005 Aug 2;46(3):480-7 - PubMed
  19. J Mol Cell Cardiol. 2015 Jan;78:35-45 - PubMed
  20. J Clin Invest. 2000 Dec;106(11):1351-9 - PubMed
  21. J Clin Invest. 1998 Oct 1;102(7):1292-300 - PubMed
  22. Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3270-8 - PubMed
  23. J Mol Cell Cardiol. 2018 Jan;114:320-327 - PubMed
  24. J Am Coll Cardiol. 2003 Jul 16;42(2):286-7 - PubMed
  25. J Am Coll Cardiol. 2012 Aug 21;60(8):705-15 - PubMed
  26. Int J Cardiol. 2018 Dec 1;272:288-297 - PubMed
  27. J Mol Cell Cardiol. 2014 Jul;72:296-304 - PubMed
  28. Eur Heart J. 2018 Nov 14;39(43):3879-3892 - PubMed
  29. N Engl J Med. 2010 Oct 7;363(15):1397-409 - PubMed
  30. Am J Physiol Heart Circ Physiol. 2014 Mar;306(6):H807-15 - PubMed
  31. Nature. 2013 Feb 7;494(7435):105-10 - PubMed
  32. Stem Cells Int. 2016;2016:1684792 - PubMed
  33. Mol Med. 2018 Mar 15;24(1):3 - PubMed
  34. J Cardiovasc Pharmacol. 2010 Aug;56(2):130-40 - PubMed
  35. BMJ Open. 2014 Jun 12;4(6):e004814 - PubMed
  36. Mol Med Rep. 2016 Dec;14(6):5573-5586 - PubMed
  37. Prog Pediatr Cardiol. 2011 May;31(2):75-81 - PubMed
  38. Cardiovasc Res. 2014 Jun 1;102(3):497-506 - PubMed
  39. J Clin Invest. 1998 Oct 15;102(8):1498-505 - PubMed
  40. Circ Res. 2017 Dec 8;121(12):1323-1330 - PubMed
  41. Circ Res. 2013 Aug 30;113(6):709-24 - PubMed
  42. Dis Model Mech. 2018 Feb 26;11(2): - PubMed
  43. Heart. 1996 Nov;76(5):412-7 - PubMed
  44. J Biol Chem. 2013 May 24;288(21):14780-7 - PubMed
  45. Circulation. 2009 Mar 3;119(8):1085-92 - PubMed
  46. J Cardiovasc Transl Res. 2018 Oct;11(5):375-392 - PubMed
  47. Eur Heart J. 2012 Dec;33(24):3023-33 - PubMed
  48. J Clin Invest. 1999 Dec;104(12):1683-92 - PubMed
  49. Nat Protoc. 2017 Jun;12(6):1177-1197 - PubMed
  50. J Am Coll Cardiol. 2003 May 21;41(10):1776-82 - PubMed
  51. Circulation. 2017 May 9;135(19):1832-1847 - PubMed
  52. Cardiovasc Res. 2010 Jun 1;86(3):461-70 - PubMed
  53. J Am Heart Assoc. 2014 Nov 11;3(6):e001263 - PubMed
  54. Stem Cell Reports. 2019 Jan 8;12(1):71-83 - PubMed
  55. Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):11238-11243 - PubMed
  56. Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8372-E8381 - PubMed
  57. Arq Bras Cardiol. 2014 Mar;102(3):295-304 - PubMed
  58. Nat Genet. 1999 Nov;23(3):333-7 - PubMed
  59. Nat Methods. 2014 Aug;11(8):855-60 - PubMed
  60. Muscle Nerve. 1990 Mar;13(3):192-4 - PubMed
  61. Histopathology. 2004 May;44(5):412-27 - PubMed
  62. Stem Cell Reports. 2018 Mar 13;10(3):808-821 - PubMed
  63. Circulation. 2009 Mar 24;119(11):1473-83 - PubMed
  64. Clin Genet. 2018 Jan;93(1):3-14 - PubMed
  65. Free Radic Biol Med. 2014 Jun;71:351-61 - PubMed
  66. Cardiovasc Res. 2000 Aug;47(2):254-64 - PubMed
  67. J Am Coll Cardiol. 2015 Mar 31;65(12):1249-1254 - PubMed
  68. J Cardiol. 2010 Nov;56(3):314-9 - PubMed
  69. Circ Res. 2011 Jun 24;109(1):86-96 - PubMed
  70. Heart Fail Clin. 2008 Jan;4(1):13-21 - PubMed
  71. J Mol Cell Cardiol. 2001 Apr;33(4):655-70 - PubMed
  72. J Cardiovasc Transl Res. 2019 Oct;12(5):394-403 - PubMed
  73. Curr Opin Genet Dev. 2016 Jun;38:38-44 - PubMed
  74. Biochim Biophys Acta. 2014 Nov;1843(11):2394-402 - PubMed
  75. J Mol Cell Cardiol. 2013 Dec;65:59-66 - PubMed
  76. Cell Mol Life Sci. 2012 Jul;69(13):2261-77 - PubMed
  77. BMJ. 2006 May 27;332(7552):1251-5 - PubMed
  78. Muscle Nerve Suppl. 1995;3:S170-4 - PubMed
  79. J Clin Invest. 1995 Jun;95(6):2465-73 - PubMed
  80. J Biol Chem. 2001 Feb 9;276(6):3743-55 - PubMed
  81. Circ Res. 2009 Jul 31;105(3):219-22 - PubMed
  82. J Clin Invest. 2008 Dec;118(12):3893-903 - PubMed
  83. PLoS One. 2014 Jul 21;9(7):e102969 - PubMed
  84. Eur Heart J. 2014 Oct 14;35(39):2733-79 - PubMed
  85. Cell. 2007 Nov 30;131(5):861-72 - PubMed
  86. Heart. 2016 Nov 15;102(22):1797-1804 - PubMed
  87. Science. 1996 May 3;272(5262):731-4 - PubMed
  88. Circ Res. 2002 Sep 20;91(6):525-31 - PubMed
  89. Circulation. 2016 Nov 15;134(20):1557-1567 - PubMed
  90. Eur Heart J. 2018 Apr 21;39(16):1446-1455 - PubMed
  91. Biochemistry. 2004 Nov 30;43(47):15058-65 - PubMed
  92. Eur Cardiol. 2017 Dec;12(2):80-82 - PubMed
  93. Cardiovasc Res. 2011 May 1;90(2):202-9 - PubMed
  94. JAMA Cardiol. 2018 Jun 1;3(6):481-488 - PubMed
  95. Mol Med. 1996 Sep;2(5):556-67 - PubMed
  96. FASEB J. 2014 Aug;28(8):3691-702 - PubMed
  97. Cell Stem Cell. 2013 Jan 3;12(1):101-13 - PubMed
  98. Am J Cardiol. 2013 Sep 15;112(6):861-6 - PubMed
  99. Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):793-8 - PubMed
  100. J Clin Invest. 1999 May 15;103(10):1459-67 - PubMed
  101. Nat Med. 2014 Jun;20(6):616-23 - PubMed
  102. J Cell Mol Med. 2018 Feb;22(2):913-925 - PubMed
  103. Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57 - PubMed
  104. Circulation. 2016 Jan 5;133(1):62-73 - PubMed
  105. Cardiovasc Res. 2014 Nov 1;104(2):258-69 - PubMed
  106. Eur Heart J. 2019 Jun 14;40(23):1832-1836 - PubMed

Publication Types

Grant support